Citigroup’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.3M | Buy |
388,087
+34,108
| +10% | +$1.4M | 0.01% | 1135 |
|
|
2026
Q1 | $11.8M | Sell |
353,979
-129,546
| -27% | -$3.86M | 0.01% | 1373 |
|
|
2025
Q4 | $14.4M | Sell |
483,525
-263,394
| -35% | -$8.6M | 0.01% | 1295 |
|
|
2025
Q3 | $27M | Buy |
746,919
+60,897
| +9% | +$2.01M | 0.01% | 907 |
|
|
2025
Q2 | $24.7M | Buy |
686,022
+336,918
| +97% | +$12.5M | 0.01% | 869 |
|
|
2025
Q1 | $13.8M | Buy |
349,104
+1,927
| +0.6% | +$64.8K | 0.01% | 1167 |
|
|
2024
Q4 | $10.5M | Buy |
347,177
+178,900
| +106% | +$5.13M | 0.01% | 1349 |
|
|
2024
Q3 | $3.94M | Buy |
168,277
+93,730
| +126% | +$2.05M | ﹤0.01% | 2055 |
|
|
2024
Q2 | $1.33M | Sell |
74,547
-454,022
| -86% | -$7.24M | ﹤0.01% | 2687 |
|
|
2024
Q1 | $8.04M | Buy |
528,569
+163,225
| +45% | +$2.6M | 0.01% | 1379 |
|
|
2023
Q4 | $6.24M | Sell |
365,344
-67,993
| -16% | -$790K | ﹤0.01% | 1456 |
|
|
2023
Q3 | $3.62M | Buy |
433,337
+233,650
| +117% | +$3.26M | ﹤0.01% | 1603 |
|
|
2023
Q2 | $4.96M | Sell |
199,687
-253,615
| -56% | -$6.55M | ﹤0.01% | 1492 |
|
|
2023
Q1 | $6.82M | Buy |
453,302
+22,351
| +5% | +$340K | ﹤0.01% | 1330 |
|
|
2022
Q4 | $5.1M | Sell |
430,951
-640,001
| -60% | -$4.65M | ﹤0.01% | 1467 |
|
|
2022
Q3 | $6.34M | Buy |
1,070,952
+294,444
| +38% | +$1.93M | ﹤0.01% | 1410 |
|
|
2022
Q2 | $3.3M | Buy |
776,508
+675,007
| +665% | +$4.21M | ﹤0.01% | 1766 |
|
|
2022
Q1 | $966K | Sell |
101,501
-410,320
| -80% | -$4.75M | ﹤0.01% | 3002 |
|
|
2021
Q4 | $9.72M | Buy |
511,821
+430,157
| +527% | +$11.2M | 0.01% | 1396 |
|
|
2021
Q3 | $2.72M | Sell |
81,664
-33,757
| -29% | -$1.04M | ﹤0.01% | 2297 |
|
|
2021
Q2 | $4.48M | Buy |
115,421
+24,114
| +26% | +$947K | ﹤0.01% | 1994 |
|
|
2021
Q1 | $4.4M | Buy |
91,307
+66,861
| +274% | +$3.21M | ﹤0.01% | 1873 |
|
|
2020
Q4 | $1.27M | Buy |
24,446
+2,836
| +13% | +$95.8K | ﹤0.01% | 3300 |
|
|
2020
Q3 | $578K | Sell |
21,610
-74,192
| -77% | -$1.71M | ﹤0.01% | 3733 |
|
|
2020
Q2 | $1.87M | Sell |
95,802
-2,520
| -3% | -$40.6K | ﹤0.01% | 2887 |
|
|
2020
Q1 | $967K | Sell |
98,322
-33,007
| -25% | -$417K | ﹤0.01% | 3214 |
|
|
2019
Q4 | $1.46M | Sell |
131,329
-99,941
| -43% | -$760K | ﹤0.01% | 3334 |
|
|
2019
Q3 | $1.3M | Sell |
231,270
-110,444
| -32% | -$770K | ﹤0.01% | 3341 |
|
|
2019
Q2 | $2.96M | Buy |
341,714
+328,907
| +2,568% | +$2.49M | ﹤0.01% | 2417 |
|
|
2019
Q1 | $103K | Sell |
12,807
-495,166
| -97% | -$2.68M | ﹤0.01% | 5719 |
|
|
2018
Q4 | $2.08M | Buy |
507,973
+336,978
| +197% | +$1.67M | ﹤0.01% | 2626 |
|
|
2018
Q3 | $958K | Buy |
170,995
+71,537
| +72% | +$817K | ﹤0.01% | 3548 |
|
|
2018
Q2 | $1.31M | Buy |
99,458
+7,013
| +8% | +$96.4K | ﹤0.01% | 3074 |
|
|
2018
Q1 | $1.31M | Sell |
92,445
-36,806
| -28% | -$470K | ﹤0.01% | 3011 |
|
|
2017
Q4 | $1.06M | Buy |
129,251
+33,036
| +34% | +$289K | ﹤0.01% | 3282 |
|
|
2017
Q3 | $1.14M | Buy |
96,215
+9,703
| +11% | +$111K | ﹤0.01% | 3235 |
|
|
2017
Q2 | $870K | Buy |
86,512
+86,163
| +24,689% | +$964K | ﹤0.01% | 3459 |
|
|
2017
Q1 | $4K | Buy |
349
+249
| +249% | +$1.79K | ﹤0.01% | 6870 |
|
|
2016
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 7333 |
|
|
2016
Q3 | $1K | Buy |
+100
| New | +$643 | ﹤0.01% | 6993 |
|
|
2016
Q2 | – | Sell |
-29,273
| Closed | -$249K | – | 7431 |
|
|
2016
Q1 | $249K | Buy |
29,273
+25,590
| +695% | +$224K | ﹤0.01% | 4868 |
|
|
2015
Q4 | $44K | Sell |
3,683
-36,669
| -91% | -$463K | ﹤0.01% | 6032 |
|
|
2015
Q3 | $407K | Buy |
40,352
+39,831
| +7,645% | +$593K | ﹤0.01% | 3939 |
|
|
2015
Q2 | $9K | Sell |
521
-1,751
| -77% | -$27.7K | ﹤0.01% | 6522 |
|
|
2015
Q1 | $36K | Sell |
2,272
-3,102
| -58% | -$47K | ﹤0.01% | 5737 |
|
|
2014
Q4 | $86K | Buy |
5,374
+4,557
| +558% | +$59.3K | ﹤0.01% | 5353 |
|
|
2014
Q3 | $9K | Buy |
817
+619
| +313% | +$5.74K | ﹤0.01% | 6328 |
|
|
2014
Q2 | $2K | Sell |
198
-2,720
| -93% | -$17.4K | ﹤0.01% | 6776 |
|
|
2014
Q1 | $20K | Sell |
2,918
-2,327
| -44% | -$13.8K | ﹤0.01% | 6030 |
|
|
2013
Q4 | $20K | Buy |
5,245
+4,619
| +738% | +$18.7K | ﹤0.01% | 6179 |
|
|
2013
Q3 | $3K | Sell |
626
-85
| -12% | -$520 | ﹤0.01% | 6536 |
|
|
2013
Q2 | $5K | Buy |
+711
| New | +$4.55K | ﹤0.01% | 6323 |
|
Other funds holding TGTX
SCM
CAM
Citigroup's TGTX Position: Q2 2026 in Review
Citigroup increased its TG Therapeutics (TGTX) stake by 9.6% in Q2 2026, buying an estimated $1.4M and bringing the position to 388,087 shares worth $21.3M. The position accounts for 0.01% of the portfolio, ranked #1135.
Citigroup first reported a position in TGTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q3 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Citigroup held 388,087 shares of TG Therapeutics worth $21.3M as of Q2 2026.
- Citigroup bought 34,108 TG Therapeutics shares in Q2 2026, an estimated $1.4M.
- TG Therapeutics made up 0.01% of Citigroup's portfolio in Q2 2026, its #1135 holding.
- Citigroup first reported a position in TG Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Citigroup's TG Therapeutics position peaked at $27M in Q3 2025.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.